Literature DB >> 10753244

Circulating neutrophil concentration and respiratory distress in premature infants.

P J Ferreira1, T J Bunch, K H Albertine, D P Carlton.   

Abstract

BACKGROUND: The acute disappearance of neutrophils from the circulation can be associated with pulmonary leukostasis, lung injury, and respiratory distress.
OBJECTIVE: To determine whether a low concentration of mature neutrophils in the peripheral blood soon after birth is associated with an increase in subsequent respiratory distress in premature infants.
DESIGN: A cohort study performed by chart review at a tertiary medical center.
SUBJECTS: Premature infants (birth weight 500 to 1250 g) who had a complete blood count obtained within 2 hours of delivery (n = 237). Patients in the lowest quartile of mature neutrophil concentrations (early neutropenia, < or =0.90 x 10(9) neutrophils/L blood) were compared with patients in the remaining 3 quartiles (control group).
RESULTS: Low neutrophil concentrations were transient in the early neutropenia group. The concentration of mature circulating neutrophils rose from 0.49 +/- 0.25 x 10(9) cells/L at an average of 1 hour after delivery to 2.8 +/- 2.2 x 10(9) cells/L within 6 to 8 hours in the early neutropenia group and from 4.6 +/- 4.8 x 10(9) cells/L to 8.2 +/- 8. 0 x 10(9) cells/L in the control group during the same time period. Respiratory support immediately after birth was similar in both groups of infants, but by 12 hours patients who had early neutropenia required significantly greater inflation pressures and concentrations of inspired oxygen. By 1 week after birth patients who had early neutropenia were more likely to require mechanical ventilation and supplemental oxygen. Pulmonary interstitial emphysema, serious intraventricular hemorrhage, and chronic lung disease occurred more frequently in patients with early neutropenia.
CONCLUSION: A low concentration of mature neutrophils in the systemic circulation of premature infants within 2 hours of birth is associated with more severe respiratory distress during the first postnatal week and with an increased risk of serious complications of prematurity.

Entities:  

Mesh:

Year:  2000        PMID: 10753244     DOI: 10.1016/s0022-3476(00)90009-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

Review 1.  Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Wes Onland; Anne Pmc De Jaegere; Martin Offringa; Anton van Kaam
Journal:  Cochrane Database Syst Rev       Date:  2017-01-31

2.  Association of BPD and IVH with early neutrophil and white counts in VLBW neonates with gestational age <32 weeks.

Authors:  M Palta; M Sadek-Badawi; D P Carlton
Journal:  J Perinatol       Date:  2008-06-19       Impact factor: 2.521

3.  Cord blood Clara cell protein CC16 predicts the development of bronchopulmonary dysplasia.

Authors:  Alexandra J J Schrama; Alfred Bernard; Ben J H M Poorthuis; Aeilko H Zwinderman; Howard M Berger; Frans J Walther
Journal:  Eur J Pediatr       Date:  2008-06-03       Impact factor: 3.183

4.  Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial.

Authors:  Wes Onland; Martin Offringa; Filip Cools; Anne P De Jaegere; Karin Rademaker; Henry Blom; Eric Cavatorta; Anne Debeer; Peter H Dijk; Arno F van Heijst; Boris W Kramer; Andre A Kroon; Thilo Mohns; Henrica L van Straaten; Arjan B te Pas; Claire Theyskens; Mirjam M van Weissenbruch; Anton H van Kaam
Journal:  BMC Pediatr       Date:  2011-11-09       Impact factor: 2.125

5.  Association between Interleukin-10-1082 G/A and Tumor Necrosis Factor-α 308 G/A Gene Polymorphisms and Respiratory Distress Syndrome in Iranian Preterm Infants.

Authors:  Abolfazl Khoshdel; Soleiman Kheiri; Peyman Omidvari; Fahimeh Moradi; Majid Hamidi; Hossein Teimori
Journal:  Mediators Inflamm       Date:  2017-02-16       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.